ASCO Data Establish Chemo-IO as Mainstay Frontline for NSCLC ASCO Data Establish Chemo-IO as Mainstay Frontline for NSCLC
Dr Jack West moderates a panel discussion with Drs Josh Bauml and Sandip Patel on the most important lung cancer trials at ASCO 2018, with a focus on chemo-immunotherapy combinations.Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news
More News: Cancer | Cancer & Oncology | Health | Hematology | Immunotherapy | Lung Cancer | Non-Small Cell Lung Cancer